Phenethyl isothiocyanate inhibits STAT3 activation in prostate cancer cells

Molecular Nutrition and Food Research

Volumn 53, Issue 7, 2009, Pages 878-886

  Gong, Aiyu ^a   He, Meilan ^a   Vanaja, Donkena Krishna ^a   Yin, Ping ^a   Jeffrey Karnes, R ^a   Young, Charles Y F ^a  

^a MAYO CLINIC   (United States)

Author keywords

Androgen independent growth; IL 6; Phenethyl isothiocyanate; STAT3

Indexed keywords

ACETYLCYSTEINE; ANDROGEN RECEPTOR; ANTINEOPLASTIC AGENT; INTERLEUKIN 6; ISOTHIOCYANIC ACID DERIVATIVE; JAK2 PROTEIN, HUMAN; JANUS KINASE 2; PHENETHYL ISOTHIOCYANATE; STAT3 PROTEIN; STAT3 PROTEIN, HUMAN;

ARTICLE; CELL CYCLE G2 PHASE; CELL DIVISION; CELL PROLIFERATION; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; HUMAN; MALE; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PROSTATE TUMOR; TUMOR CELL LINE;

ACETYLCYSTEINE; ANTICARCINOGENIC AGENTS; CELL DIVISION; CELL LINE, TUMOR; CELL PROLIFERATION; G2 PHASE; HUMANS; INTERLEUKIN-6; ISOTHIOCYANATES; JANUS KINASE 2; MALE; PHOSPHORYLATION; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; STAT3 TRANSCRIPTION FACTOR;

EID: 68149167106     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.200800253     Document Type: Article

References (44)

1. Zhang, S. S., Liu, M. G., Kano, A., Zhang, C. et al., STAT3 activation in response to growth factors or cytokines participates in retina precursor proliferation, Exp. Eye Res. 2005, 81,103-115.
2. Lou, W., Ni, Z., Dyer, K., Tweardy, D. J., Gao, A. C., Interleukin-6 induces prostate cancer cell growth accompanied by activation of STAT3 signaling pathway, Prostate 2000, 42, 239-242.
3. Heinrich, P., Behmann, I., Muller-Newen, G., Schaper, F., Graeve, L., Interleukin-6-type cytokine signalling though the gp130/Jak/STAT pathway, Biochem. J. 1998, 334, 297-314.
4. Wallner, L., Dai, J., Escara-Wilke, J., Zhang, J. et al., Inhibition of interleukin-6 with CNTO328, an anti-interleukin-6 monoclonal antibody, inhibits conversion of androgen-dependent prostate cancer to an androgen-independent phenotype in orchiectomized mice, Cancer Res. 2006, 66, 3087-3095.
5. Barton, B. E., Murphy, T. F., Shu, P., Huang, H. F. et al., Novel single-stranded oligonucleotides that inhibit signal transducer and activator of transcription 3 induce apoptosis invitro and in vivo in prostate cancer cell lines, Mol. Cancer Ther. 2004,3,1183-1191.
6. Okamoto, M., Lee, C., Oyasu, R., Interleukin-6 as a paracrine and autocrine growth factor in human prostatic carcinoma cells in vitro, Cancer Res. 1997, 57, 141-146.
7. Mora, L. B., Buettner, R., Seigne, J., Constitutive activation of Stat3 in human prostate tumors and cell lines: Direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells, Cancer Res. 2002, 62, 6659-6666.
8. Tam, L., Mcglynn, L. M., Traynor, P., Mukherjee, R. et al., Expression levels of the JAK/STAT pathway in the transition from hormone-sensitive to hormone-refractory prostate cancer, Br. J. Cancer 2007, 97, 378-383.
9. Buettner, R., Huang, M., Gritsko, T., Karras, J. et al., Activated signal transducers and activators of transcription 3 signaling induces CD46 expression and protects human cancer cells from complement-dependent cytotoxicity, Mol. Cancer Res. 2007, 5, 823-832.
10. Wand, T., Niu, G., Kortylewski, M., Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells, Nat. Med. 2004, 10, 48-54.
11. Fahey, J. W., Zalcmann, A. T., Talalay, P., The chemical diversity and distribution of glucosinolates and isothiocyanates among plants, Phytochemistry 2001, 56, 5-51.
12. Hayes, J. D., Kelleher, M. O., Eggleston, I. M., The cancer chemopreventive actions of phytochemicals derived from glucosinolates, Eur. J. Nutr. 2008, 47 (Suppl 2), 73-88.
13. Xiao, D., Lew, K. L., Zeng, Y., Xiao, H. et al., Phenethyl iso-thiocyanate-induced apoptosis in PC-3 human prostate cancer cells is mediated by reactive oxygen species-dependent disruption of the mitochondrial membrane potential, Carcinogenesis 2006, 27, 2223-2234.
14. Wang, L. G., Liu, X. M., Chial, J. W., Repression of androgen receptor in prostate cancer cells by phenethyl isothiocyanate, Carcinogenesis 2006, 27, 2124-2132.
15. Hu, J., Straub, J., Xiao, D., Singh, S. V. et al., Phenethyl iso-thiocyanate, a cancer chemopreventive constituent of cruciferous vegetables, inhibits cap-dependent translation by regulating the level and phosphorylation of 4E-BP1, Cancer Res. 2007,67,3569-3573.
16. Xiao, D., Singh, S. V., Phenethyl isothiocyanate inhibits angiogenesis in vitro and ex vivo, Cancer Res. 2007, 67, 2239-2246.
17. Chung, T. D. K., Yu, J., Spiotto, M. T., Bartkowski, M., Simons, J. W., Characterization of the role of IL-6 in the progression of prostate cancer, Prostate 1999, 38, 199-207.
18. Horvach, C. M., The Jak-STAT pathway stimulated by inter-leukin 6, Sci. STKE 2004, 23, 260.
19. Lee, S. O., Lou, W., Gao, A. C., Interleukin-6 promotes androgen-independent growth in LNCaP human prostate cancer cells, Clin. Cancer Res. 2003, 9, 370-376.
20. Trachootham, D., Zhou, Y., Zhang, H., Demizu, Y. et al., Selective killing of oncogenically transformed cells though a ROS-mediated mechanism by beta-phenylethyl isothiocyanate, Cancer Cell 2006, 10, 241-252.
21. Xiao, D., Lew, K. L., Zeng, Y., Xiao, H. et al., Phenethyl iso-thiocyanate-induced apoptosis in PC-3 human prostate cancer cells is mediated by reactive oxygen species-dependent disruption of the mitochondrial membrane potential, Carcinogenesis 2006, 27, 2223-2234.
22. Zhang, H., Trachootham, D., Lu, W., Carew, J. et al., Effective killing of Gleevec-resistant CML cells with T315I mutation by a natural compound PEITC through redox-mediated mechanism, Leukemia 2008, 22, 1191-1199.
23. Xu, C., Yuan, X., Pan, Z., Shen, G. et al., Mechanism of action of isothiocyanates: The induction of ARE-regulated genes is associated with activation of ERK and JNK and the phosphorylation and nuclear translocation of Nrf2, Mol. Cancer Ther. 2006, 5, 1918-1926.
24. Chen, C. D., Welabie, D. S., Tran, C., Molecular determinants of resistance to antiandrogen therapy, Nat. Med. 2004, 10, 33-39.
25. Dehm, S. M., Tindall, D. J., Molecular regulation of androgen action in prostate cancer, J. Cell. Biochem. 2006, 99, 333-344.
26. Rose, J. S., Waetzig, G. H., Scheller, J., Grotzinger, J., Seegert, D., The IL-6/sIL-6R complex as a novel target for therapeutic approaches, Expert Opin. Ther. Targets 2007, 11, 613-624.
27. Giri, D., Ozen, M., Ittmann, M., Interleukin-6 is an autocrine growth factor in human prostate cancer, Am. J. Pathol. 2001, 159,2159-2165.
28. Dhir, R., Ni, Z. Y., Lou, W., DeMiguel, F. et al., Stat3 activation in prostatic carcinomas, Prostate 2002, 51, 241-246.
29. Ueda, T., Bruchovsky, N., Sadar, M. D., Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways, J. Biol. Chem. 2002, 277, 7076-7085.
30. Smith, P. C., Hobisch, A., Lin, D. L., Culig, Z., Keller, E. T., Interleukin-6 and prostate cancer progression, Cytokine Growth Factor Rev. 2001, 12, 33-40.
31. Aaronson, D. S., Muller, M., Neves, S. R., Chung, W. C. et al., An androgen-IL6-Stat3 autocrine loop re-routes EGF signal in prostate cancer cells, Mol. Cell. Endocrinol. 2007, 270, 50-56.
32. Verhoeven, D. T., Goldbohm, R. A., van Poppel, G., Verhagen, H., van den Brandt, P. A., Epidemiological studies on brassica vegetables and cancer risk, Cancer Epidemiol. Biomarkers Prev. 1996, 5, 733-748.
33. Mi, L., Wang, X., Govind, S., Hood, B. L. et al., The role of protein binding in induction of apoptosis by phenethyl iso-thiocyanate and sulforaphane in human non-small lung cancer cells. Cancer Res. 2007, 67, 6409-6416.
34. Ferguson, L. R., Philpott, M., Cancer prevention by dietary bioactive components that target the immune response, Curr. Cancer Drug Targets 2007, 7, 459-464.
35. Xiao, D., Zeng, Y., Choi, S., Lew, K. L. et al., Caspase-dependent apoptosis induction by phenethyl isothiocyanate, a cruciferous vegetable-derived cancer chemopreventive agent, is mediated by Bak and Bax, Clin. Cancer Res. 2005, 11, 2670-2679.
36. Xu, C., Shen, G., Chen, C., Gelinas, C., Kong, A. N., Suppression of NF-kappaB and NF-kappaB-regulated gene expression by sulforaphane and PEITC through IkappaBalpha, IKK pathway in human prostate cancer PC-3 cells, Oncogene 2005,24,4486-4495.
37. Xiao, D., Singh, S. V., Phenethyl isothiocyanate-induced apoptosis in p53-deficient PC-3 human prostate cancer cell line is mediated by extracellular signal-regulated kinases, Cancer Res. 2002, 62, 3615-3619.
38. Matsuda, T., Junicho, A., Yamamoto, T., Kishi, H. et al., Cross-talk between signal transducer and activator of transcription 3 and androgen receptor signaling in prostate carcinoma cells, Biochem. Biophys. Res. Commun. 2001, 283, 179-187.
39. Kim, B. M., Chung, H. W., Hypoxia/reoxygenation induces apoptosis through a ROS-mediated caspase-8/Bid/Bax pathway in human lymphocytes, Biochem. Biophys. Res. Commun. 2007, 363, 745-750.
40. Ko, C. H., Shen, S. C., Yang, L. Y., Lin, C. W., Chen, Y. C., Gossypol reduction of tumor growth through ROS-dependent mitochondria pathway in human colorectal carcinoma cells, Int. J. Cancer 2007, 121, 1670-1679.
41. Chen, Y. R., Wang, W., Kong, A. N., Tan, T. H., Molecular mechanisms of c-Jun N-terminal kinase-mediated apoptosis induced by anticarcinogenic isothiocyanates, J. Biol. Chem. 1998,273,1769-1775.
42. Kim, Y. A., Xiao, D., Xiao, H., Powolny, A. A. et al., Mito-chondria-mediated apoptosis by diallyl trisulfide in human prostate cancer cells is associated with generation of reactive oxygen species and regulated by Bax/Bak, Mol. Cancer Ther. 2007,6,1599-1609.
43. Chiao, J. W., Chung, F., Krzeminski, J., Amin, S. et al., Modulation of growth of human prostate cancer cells by the N-acetylcysteine conjugate of phenethyl isothiocyanate, Int. J. Oncol. 2000, 16, 1215-1219.
44. Xu, K., Thornalley, P. J., Involvement of glutathione metabolism in the cytotoxicity of the phenethyl isothiocyanate and its cysteine conjugate to human leukaemia cells in vitro, Biochem. Pharmacol. 2001, 61, 165-177.